Application 219404
- Type
- ANDA
- Sponsor
- LUPIN LIMITED
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 002 | OXCARBAZEPINE EXTENDED RELEASE TABLETS | OXCARBAZEPINE | TABLET;EXTENDED RELEASE | 300MG | No | No |
| 003 | OXCARBAZEPINE EXTENDED RELEASE TABLETS | OXCARBAZEPINE | TABLET;EXTENDED RELEASE | 600MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Oxcarbazepine | OXCARBAZEPINE | NCS HealthCare of KY, LLC dba Vangard Labs | a14b5756-4fd1-4ba7-bc23-e1fa9212a148 | 2026-05-18 | Warnings, Adverse reactions | OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Coupler LLC | 512ab25c-ea79-1e59-e063-6294a90ae9a0 | 2026-05-06 | Warnings, Adverse reactions | OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Umedica Laboratories USA Inc. | e46d4654-76bc-4c33-ac2b-e89ae11b7697 | 2026-05-05 | Warnings, Adverse reactions | OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Coupler LLC | 51008af2-39ac-546c-e063-6294a90a758f | 2026-05-04 | Warnings, Adverse reactions | OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | Major Pharmaceuticals | 567c0777-9bc5-45a9-ba25-959dd76d0e05 | 2026-04-30 | Warnings, Adverse reactions | OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Coupler LLC | 50873ef7-3deb-7386-e063-6394a90a9c19 | 2026-04-28 | Warnings, Adverse reactions | OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Bryant Ranch Prepack | 87f53c04-075c-4d09-925a-0faeaa14f3f9 | 2026-04-23 | Warnings, Adverse reactions | OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | Breckenridge Pharmaceutical, Inc. | 54fb494e-bce4-442d-954a-757f9851e81e | 2026-04-13 | Warnings, Adverse reactions | OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Bryant Ranch Prepack | 148b90ba-236a-47cc-b171-22dd7f8f8e0a | 2026-03-20 | Warnings, Adverse reactions | OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | NorthStar RxLLC | 20d826cd-fa4a-4570-9e10-9d7d10fb725b | 2026-03-17 | Warnings, Adverse reactions | OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Advagen Pharma Limited | b0bc10f0-7d1b-4adc-bc59-c48dab58ee5a | 2026-02-24 | Warnings, Adverse reactions | OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Advagen Pharma Ltd. | ab4c1f36-82fa-40a2-a31a-227875d0f382 | 2026-02-04 | Warnings, Adverse reactions | OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | REMEDYREPACK INC. | 244f9a68-5ab4-46b8-a01f-538572fd3c5f | 2026-02-03 | Warnings, Adverse reactions | OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | REMEDYREPACK INC. | 6d2a6cac-f16b-4e6c-8f75-3afffb0a0f3b | 2026-02-03 | Warnings, Adverse reactions | OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Camber Pharmaceuticals, Inc. | fe49a773-562c-4da6-96b7-bba52f4d61e2 | 2026-01-30 | Warnings, Adverse reactions | OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | Advagen Pharma Ltd | 4ef6a941-a017-40f2-a50a-ab66c43b3347 | 2026-01-13 | Warnings, Adverse reactions | OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Chartwell RX, LLC | c2affa00-1d57-4d85-8db3-745191b4714d | 2026-01-08 | Warnings, Adverse reactions | OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Coupler LLC | 47b92168-6832-1e0b-e063-6394a90a079a | 2026-01-06 | Warnings, Adverse reactions | OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Chartwell Governmental & Specialty RX, LLC. | e74bb389-8426-4ffc-a14b-a5990de6d0d4 | 2025-12-26 | Warnings, Adverse reactions | OXCARBAZEPINE |
| Trileptal | OXCARBAZEPINE | Novartis Pharmaceuticals Corporation | 4c5c86c8-ab7f-4fcf-bc1b-5a0b1fd0691b | 2025-12-16 | Warnings, Adverse reactions | OXCARBAZEPINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.